Part Details | USP AMITRIPTYLINE HYDROCHLORIDE TABLETS
6505-00-947-1898
Alternate Parts: NDC00223019702, NDC00223-0197-02, NDC00781148810, NDC00781-1488-10, NDC00904020280, NDC00904-0202-80, NDC54868006600, NDC54868-0066-00, NDC53489010610, NDC53489-0106-10, NDC00378265010, NDC00378-2650-10, NDC00536307310, NDC00536-3073-10, NDC00781148810, NDC00781-1488-10, NDC00364057502, NDC00364-0575-02, NDC003100041034, NDC00310-00410-34, NDC00038004134, NDC00038-0041-34, 6505-00-947-1898, 00-947-1898, 6505009471898, 009471898
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | MAR 23, 1966 | 00-947-1898 | 30902 ( AMITRIPTYLINE HYDROCHLORIDE TABLETS, USP ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-00-947-1898
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC00223-0197-02 | 21016 | CONSOLIDATED MIDLAND CORP |
| NDC00781-1488-10 | 59043 | GENEVA PHARMACEUTICALS INC |
| NDC00904-0202-80 | 0SYT3 | MAJOR PHARMACEUTICALS INC |
| NDC54868-0066-00 | 9L698 | MEDICAL AND SAFETY GROUP INCDBA INDUSTRIAL DRUG SERVICE |
| NDC53489-0106-10 | 0A539 | MUTUAL PHARMACEUTICAL COMPANY, INC.DBA URL PHARMA |
| NDC00378-2650-10 | 60895 | MYLAN PHARMACEUTICALS INC |
| NDC00536-3073-10 | 4V824 | RUGBY GROUP INC |
| NDC00781-1488-10 | 0THL4 | SANDOZ INC. |
| NDC00364-0575-02 | 0PTT8 | SCHEIN PHARMACEUTICAL INC |
| NDC00310-00410-34 | 13992 | ZENECA INCZENECA PHARMACEUTICALS GROUP |
| NDC00038-0041-34 | 13992 | ZENECA INCZENECA PHARMACEUTICALS GROUP |
Technical Data | NSN 6505-00-947-1898
| Characteristic | Specifications |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | AB50.000 MILLIGRAMS AMITRIPTYLINE HYDROCHLORIDE |
| ADMINISTRATION | ORAL |
| COATING FEATURE | FILM, NONENTERIC |
| PRIMARY CONTAINER TYPE | BOTTLE |
| PRIMARY CONTAINER CONTENT QUANTITY | 1000.000 TABLETS |
| THERAPEUTIC EQUIVALENT | BARR LABORATORIES |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | AMITRIPTYLINE HYDROCHLORIDE TABLETS USP 50MG 1000S BT |